BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $100 at Credit Suisse
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $64.38 +0.69%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 5 | New: 25
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 5 | New: 25
Join SI Premium – FREE
Credit Suisse analyst Martin Auster lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $100.00 (from $102.00) while maintaining a Outperform rating.
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $97 at BMO Capital
- Teradata (TDC) PT Lowered to $32 at UBS on Cautious Q3 View
- BofA Securities Upgrades Candel Therapeutics Inc. (CADL) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
